(UroToday.com) In an educational session at the American Society for Radiation Oncology (ASTRO) Annual Congress focused on the best treatment for early prostate cancer, Dr. Stephenson presented on the potential role of focal therapy as an alternative for whole-gland therapy for intermediate-risk prostate cancer.